After a historic year at EvoNexus in 2021, we worked hard to keep the momentum alive throughout 2022! Over the course of 12 months, EvoNexus portfolio companies raised a total of $360 million, with a record-breaking $110 million raised by our current portfolio companies. We also saw three of our graduate companies acquired: TapHunter, Guru, and Evasyst (Kast).
Throughout the year, we have seen companies grow, products being developed, and companies return to in-person incubation. EvoNexus has also continued to grow throughout 2022, electing the following new board directors:
Are you a company founder or know a company that would be a great fit for EvoNexus? We are currently accepting rolling applications to join our San Diego Incubator. Follow the link below to begin our application process. We look forward to learning more about your innovations!
Our success is a result of the close partnerships we have with some of the world’s leading influential companies, as well as a deep bench of early-stage investors! EvoNexus, further succeeds thanks to the support we receive from our volunteers, selection committee members, and top providers of professional services.
If your company wants to get involved and/or partner with EvoNexus, follow the link below to connect with us.
There have been many highlights this past year beginning with the move into our new facility, at 5015 Shoreham Place. The new office has been optimized for a return to facility-based incubation and provides an event area that has allowed us to re-launch our Special Interest Group (SIG) Events! In July we kicked off the SIGs with two 5G SIGs, two Military SIGs, a MedTech SIG, and a Cybersecurity SIG. In 2023, we anticipate more SIG events, as well as the return of our start-up Demo Day and Headliner Events,both at the Irwin M. Jacobs Qualcomm Hall.
In November, we announced our second year of partnering with Qualcomm on the 5G Technology Incubator. Qualcomm will be working closely with EvoNexus to identify early-stage companies bridging emerging technologies and use cases with the compelling attributes of the 5G network. We are excited about the opportunities this will bring us and the San Diego community throughout 2023!
This year we have seen multi-national companies return to EvoNexus's new location to meet with our portfolio companies. Companies meeting with our start-ups include LG, Murata, Sony, and HP. In addition to corporate partners, venture capital funds are also returning to EvoNexus for in-person meetings with our start-ups.
Working from home over the past three years made it difficult to foster relationship-building between portfolio companies, corporate partners, investors, and our staff. We are changing that through special events to help build camaraderie and celebrate all of our accomplishments.
Pleno, a multi-omic instrument platform company revolutionizing biological target detection for clinical testing and biomedical research, has raised $40M in Series A financing led by Deerfield Management Company with participation by Foresite Capital. This is the largest Series A round in the history of EvoNexus!
Brelyon, the MIT spin-off pioneering a new category of ultra-immersive display technologies has raised $15M in Series A financing led by Lockheed Martin Ventures and the MIT-affiliated E14 Fund with participation from Corning Incorporated, LG Technology Ventures, UDC Ventures, and Franklin Templeton.
The Good Face Project, the innovation platform for the next generation of beauty, has raised a $5.65M seed investment round led by VMG Catalyst to infuse scientific ingredient-level data and insights into the research and development and innovation cycle for cosmetics.
Ixana (formerly Hearcomm), the wearable hardware company developing high-speed human-computer interfaces closed $3M in seed funding backed by Uncorrelated Ventures, Samsung Next, EvoNexus, Paradigm Shift, and Hack VC.
Housecall Pro, a unicorn status industry-leading software platform trusted by over 25,000 home service companies, has raised $125M in additional funding from Permira Growth Opportunities and Vista Credit Partners.
Carlsmed, a developer of a spinal implant device and medical system, closed an oversubscribed $30M Series B funding round, led by B Capital Group, a global, multi-stage investment firm. Existing investors, U.S. Venture Partners, The Vertical Group, Cove Fund and Wavemaker Three-Sixty Health, also participated in the round.
Syntiant, a provider of semiconductor solutions for edge AI such as the always-on voice and audio product sector such as Alexa has closed $55M in their Series C funding, bringing the total investment to more than $120M since the company’s founding in 2017.
Micruity, (about) has closed $5.1M in seed financing to accelerate the expansion of its income connectivity platform that powers annuities inside 401(k) plans, turning retirement savings into protected retirement income.
Tag-N-Trac, a logistics tracking company launched out of stealth with $10M in new funding. Dell Technologies led the Series A round, with Merck Global Innovation Fund and Aerosafe Global also participating.
Daasity, an e-commerce analytics and data company, secured $15M in Series A funding as it continues developing its approach to helping consumer brands better leverage their customer data to make smarter decisions.
Brelyon and LG Display today announced a strategic cooperation under which Brelyon will integrate LG Display’s P-OLED technology into its ultra-immersive, virtual monitors.
Independa, a developer of remote engagement technology systems and LG, bring telehealth to Smart TVs with their built-in app and new functions to contact health professionals directly from the large display.
iCoin, the developer of a cold storage digital currency wallet designed to safely interact with blockchain-based applications announced a first-of-its kind cold storage wallet for digital currency and NFTs and secure messaging. iCoin also announced that it has signed a distribution agreement with Verizon to sell the iCoin Wallet System.
Cardea Bio Inc, the world’s only mass producer of biocompatible semiconductors, announced a significant milestone with the launch of CRISPR-QC as a separate business using Cardea’s CRISPR-chip technology for a range of quality control services for CRISPR gene editing. This milestone is an important move for Cardea Bio on its mission to realizing real-world applications of their Biosignal Processing Unit (BPU) Platform.
Advanced Image Robotics, a fully-integrated remote video production company, won the 2022 NAB Innovation Award and Product of the Year.
UCAP Power, the manufacturer of ultracapacitor-based power solution systems intended for the rapid release and storage of energy was named an Edison Award Winner.
Astrome Technologies, an India and US-based 5G/satellite communication company is partnering with UK-based Methera Global Communications to establish next-generation satellite broadband internet with a focus on supporting India and international markets.
QuSecure’s industry-leading post-quantum cybersecurity solution wins Army’s xTechSearch 6 Competition for Innovative Technology and wins 2022 New Product of the Year Award as Best Quantum Cybersecurity Solution.
Sateliot, developer of a satellite telecom network designed to offer continuous global IoT connectivity under the 5G protocol, partners with telecom giant Telefónica to test a connectivity service that will integrate Sateliot’s satellite network with Telefónica Tech’s current terrestrial NB-IoT networks for the delivery of IoT connectivity wherever needed.
Carlsmed - enrolls 1st patients in a clinical trial evaluating the outcomes of patients who underwent spine surgery with aprevo, Carlsmed's patient-specific spine implant. The study will assess spinal alignment, complications and patient-reported outcome measures for a variety of patients with degenerative spinal conditions.
SOCi Inc., the marketing platform for multi-location brands, has announced the company has completed and passed the required audits to become ISO 27001 certified. ISO 27001 certification confirms that SOCi meets the highest standards for information security and security management.
PacBio, a developer of high-quality, highly accurate genomic sequence solutions, has become the first and onlycompany to offer both native long- and short-read genomic sequencing technology, following their acquisition of EvoNexus portfolio company Omniome in 2021.
QuSecure signs a distribution agreement with Arrow Electronics to distribute their post-quantum cybersecurity products to Arrow’s 220,000+ technology manufacturers and service providers. Arrow will marshal its 8,000-person sales force to bring the QuProtect solution to its federal and commercial customer base.
Sateliot, continues to put together the pieces of its network, announcing the week of November 8th that its first functional low-Earth orbit (LEO) satellite is expected to hitch a ride on a SpaceX launch in the first quarter of 2023.
TruMed Systems, a medical inventory management company, announced on November 15th a new integration with Helmer Scientific providing a solution for access-controlled cold storage for vaccines and medications requiring refrigeration and freezing. Helmer Scientific is a leading manufacturer of cold storage products and processing equipment. By partnering with TruMed, customers will now benefit from enhanced vaccine management and access control capabilities on Helmer refrigerators and freezers.
Brelyon, and Lockheed Martin Corporation showcased the latest Brelyon solution to transform the immersive simulation experience at I/ITSEC, the largest training and simulation tradeshow in the United States. Brelyon's Ultra Reality display was paired with Lockheed Martin’s F-16 Pilot Training Aid.
Syntiant, announced on December 13th that the company was named 2022’s “Start-Up to Watch” during this year’s Global Semiconductor Alliance (GSA) Awards.
CARI Health, founded by Patrik Schmidle, is developing a remote medication monitor that will enable clinicians to view medication levels in real-time and customize dosages for every patient. These pain free, small, wireless sensors are worn on the patient’s skin and continuously send data about medication levels to the CARI cloud. If medication levels fall outside of the desired range, then alerts may be sent to clinicians, patients, and family members. The first application for this solution will be for opioid use disorder patients, who can prove treatment compliance via CARI's wearable remote monitor instead of having to visit a clinic every day. CARI's solution will improve patients' quality of life, reduce healthcare costs, and save lives.
MeCo Diagnostics, founded by Adam Watson, is the developer of a biotech research company intended to prevent breast cancer patients from the risk of metastasis. The company develops a prognostic and predictive biomarker for the risk of metastasis caused by mechanical conditioning, and it provides the rationale for targeted prevention in high-risk patients using low toxicity antifibrotic drugs, enabling breast cancer patients to get benefits from the therapy.
EvoNexus, 5015 Shoreham Place, Suite 150, San Diego, CA 92122, United States
